Expert Opinion on Biological Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 4.0 | Q2 | 63.9% | 1.045 | Q1 | 85.1% |
| 2024 | 4.0 | Q2 | 72.3% | 1.150 | Q1 | 87.5% |
| 2023 | 3.6 | Q2 | 64.2% | 1.104 | Q1 | 87.8% |
| 2022 | 4.6 | Q2 | 69.6% | 1.120 | Q1 | 88.6% |
| 2021 | 5.6 | Q2 | 76.4% | 1.001 | Q1 | 86.5% |
| 2020 | — | — | 1.088 | Q1 | 87.1% | |
| 2019 | — | — | 0.917 | Q1 | 83.7% | |
| 2018 | — | — | 1.133 | Q1 | 86.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-7682
ISSN
1471-2598
region
Western Europe
coverage
2001-2026